Clinical Trials Directory

Trials / Completed

CompletedNCT03483610

Promoting Cervical Cancer Screening for Emergency Department Patients

Piloting Interventions to Improve Adherence to Cervical Cancer Screening Recommendations Among Emergency Department Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
95 (actual)
Sponsor
University of Rochester · Academic / Other
Sex
Female
Age
21 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to learn methods to encourage women to get recommended cervical cancer screening. Cervical cancer screening is an important part of cervical cancer prevention. The study team will determine if the patient is currently up-to-date with cervical cancer screening recommendations. If the patient is not up-to-date, then they will be randomly assigned to one of two interventions. One intervention consists only of referral to a women's health care provider to obtain cervical cancer screening. The other intervention consists of receiving a total of 3 text messages at 30-day intervals encouraging follow-up for cervical cancer screening.

Conditions

Interventions

TypeNameDescription
BEHAVIORALProvider ReferralParticipants will be asked if they are up-to-date on their cervical cancer screening. If not they will be referred to a provider. At the end of the study they will receive a 10 minute follow up telephone survey to collect data screening status and views on cervical cancer screening.
BEHAVIORALText MessagingParticipants will be asked if they are up-to-date on their cervical cancer screening. If not they will be referred to a provider. They will also receive a total of 3 text messages at 30-day intervals encouraging follow-up for cervical cancer screening. They will receive a 10 minute follow up telephone survey to collect data screening status and views on cervical cancer screening.

Timeline

Start date
2018-06-25
Primary completion
2019-05-31
Completion
2019-05-31
First posted
2018-03-30
Last updated
2025-01-24
Results posted
2025-01-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03483610. Inclusion in this directory is not an endorsement.